EPB41L4A and Miyoshi myopathy: 2) The molecular typing by MAF, MMSET, and Proliferation suggested that MM had a poor prognosis.44 We found that the expression of EPB41L4A in these molecular typing was significantly lower than the average of all 7 molecular typing.